Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |